REGN Filing
10-QFiling Date: Jul 30, 2026

REGENERON PHARMACEUTICALS, INC. (REGN) · Quarterly Report (10-Q) SEC Filing

regn-20260630

descriptionView SEC Filing
ACC: 0000872589-26-000025open_in_new
Key Financial MetricsFY2026 · 2026-06-30
Revenue$4.29B
Net Income$1.30B
Total Assets$41.73B
Stockholders' Equity$31.71B
Operating Cash Flow$1.89B

keid AI analysis is for reference only and does not constitute investment advice.